Gordon Kuntz
Subject Matter Expert: Oncology Pathways, Pharmaceuticals, and Value-Based Care
Gordon’s expertise includes over 20 years working in the cancer space for a variety of companies directly and as a consultant. Through his broad experience, Gordon has developed a unique understanding of the entire cancer care ecosystem.
Since 2004, Gordon has worked in the business of oncology for a variety of organizations, including US Oncology, ION Solutions/AmerisourceBergen, Via Oncology/Elsevier, a large NCI Cancer Center, and multiple drug companies. He is a though leader and subject matter expert regarding payer relations/payer programs, value-based care, practice economics, and oncology clinical pathways. A member of the editorial board of the Journal of Clinical Pathways, he has contributed numerous articles and has moderated the Oncology Clinical Pathways Congress since 2019. Gordon hosts the video podcast series entitled Oncology Innovations and is a frequent speaker on the cancer care ecosystem and the business of oncology.
Gordon currently consults with pharma manufacturers and others, providing strategic advice on issues that impact and influence pathways, quality and value programs, practice economics, and payer perspectives.